PulseAugur
EN
LIVE 16:53:05

Open-source tool grants AI full access to pharma R&D data

By PulseAugur Editorial · [3 sources] ·

An open-source project called drug-pipeline-mcp has been released, offering AI agents comprehensive access to pharmaceutical R&D data. This tool aggregates information on clinical trials, FDA/EMA approvals, safety reports, drug labels, patent expirations, recalls, and PubMed publications. The project aims to provide AI with deep insights into drug development pipelines, enabling queries like "What's in Novo Nordisk's pipeline?" The initiative is licensed under MIT and is available on GitHub. AI

IMPACT Provides AI agents with structured access to comprehensive pharmaceutical R&D data, potentially accelerating drug discovery and analysis.

RANK_REASON Release of an open-source tool that integrates various data sources for AI agents.

Read on dev.to — MCP tag →

AI-generated summary · Google Gemini · from 3 sources. How we write summaries →

Open-source tool grants AI full access to pharma R&D data

COVERAGE [3]

  1. dev.to — MCP tag TIER_1 Français(FR) · DasClown ·

    drug-pipeline-mcp: Open-source pharmaceutical R&D intelligence

    <h2> drug-pipeline-mcp — Pharmaceutical R&amp;D Pipeline Intelligence </h2> <p><a href="https://github.com/DasClown/drug-pipeline-mcp" rel="noopener noreferrer">https://github.com/DasClown/drug-pipeline-mcp</a></p> <p>An MCP server that gives AI agents full visibility into pharma…

  2. Mastodon — sigmoid.social TIER_1 English(EN) · [email protected] ·

    pub2cal AI/ML studies show a rapid increase. 🤖 Only 7.6% FDA regulated. 🔬 56.2% randomized, 58.9% prospective. 🏥 44.2% hospital/clinic-sponsored. 🌍 75.3% from h

    pub2cal AI/ML studies show a rapid increase. 🤖 Only 7.6% FDA regulated. 🔬 56.2% randomized, 58.9% prospective. 🏥 44.2% hospital/clinic-sponsored. 🌍 75.3% from high-income countries. # AI # ML # ClinicalTrials https:// tnyp.me/a6XwRVdg/m

    LINKS jmir.org/…/e57750
  3. Mastodon — sigmoid.social TIER_1 English(EN) · [email protected] ·

    AI/ML studies from ClinicalTrials.gov (2010-2023). 🔍7.6% FDA-regulated More: https://dev. https:// tnyp.me/zSUL1QX1/m # AI # ML # Trends # Healthcare # Clinical

    AI/ML studies from ClinicalTrials.gov (2010-2023). 🔍7.6% FDA-regulated More: https://dev. https:// tnyp.me/zSUL1QX1/m # AI # ML # Trends # Healthcare # ClinicalTrials # Pub2Post

    LINKS tnyp.me/…/m

RELATED ENTITIES

RELATED TOPICS